US5188826A
(en)
*
|
1988-02-08 |
1993-02-23 |
Insite Vision Incorporated |
Topical ophthalmic suspensions
|
US5521222A
(en)
*
|
1989-09-28 |
1996-05-28 |
Alcon Laboratories, Inc. |
Topical ophthalmic pharmaceutical vehicles
|
US5461081A
(en)
*
|
1989-09-28 |
1995-10-24 |
Alcon Laboratories, Inc. |
Topical ophthalmic pharmaceutical vehicles
|
US5252318A
(en)
*
|
1990-06-15 |
1993-10-12 |
Allergan, Inc. |
Reversible gelation compositions and methods of use
|
US5460834A
(en)
*
|
1991-12-13 |
1995-10-24 |
Alcon Laboratories, Inc. |
Combinations of polymers for use in physiological tear compositions
|
EP0551626A1
(en)
*
|
1991-12-19 |
1993-07-21 |
LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d. |
Thermoreversible gel as a liquid pharmaceutical carrier for a galenic formulation
|
WO1993017664A1
(en)
*
|
1992-03-02 |
1993-09-16 |
Alcon Laboratories, Inc. |
Combinations of cellulosic polymers and carboxy vinyl polymers and their use in pharmaceutical compositions
|
SE512871C2
(sv)
*
|
1992-08-20 |
2000-05-29 |
Santen Oy |
Oftalmologisk beredning innehållande pilokarpin och ytterligare medel för behandling av okular hypertension
|
DK0661045T3
(da)
*
|
1992-09-18 |
2002-10-28 |
Yamanouchi Pharma Co Ltd |
Hydrogelpræparat med forsinket frigivelse
|
DE69327878T2
(de)
*
|
1993-04-16 |
2000-06-15 |
Wakamoto Pharma Co Ltd |
Unter wärmeeinwirkung reversibel gelierende medizinische zusammensetzung auf wasserbasis
|
AU6973094A
(en)
*
|
1993-06-24 |
1995-01-17 |
Leiras Oy |
Composition for ophthalmic use
|
EP0664699A1
(en)
*
|
1993-08-13 |
1995-08-02 |
Vitaphore Corporation |
Hydrogel-based microsphere drug delivery systems
|
KR950007873A
(ko)
*
|
1993-09-20 |
1995-04-15 |
후꾸하라 요시하루 |
생리 활성 물질 지속 방출형의 의약 제제
|
US5458879A
(en)
*
|
1994-03-03 |
1995-10-17 |
The Procter & Gamble Company |
Oral vehicle compositions
|
ATE206441T1
(de)
|
1994-03-04 |
2001-10-15 |
Univ Washington |
Block- und pfropfcopolymere und dazu gehöriges verfahren
|
SE9401109D0
(sv)
*
|
1994-03-31 |
1994-03-31 |
Leiras Oy |
Opthalmic composition II
|
SE9401108D0
(sv)
*
|
1994-03-31 |
1994-03-31 |
Leiras Oy |
Ophthalmic composition I
|
US5585398A
(en)
*
|
1994-07-15 |
1996-12-17 |
Ernst; Amy A. |
Topical anesthetic comprising lidocaine, adrenaline, and tetracaine, and its method of use
|
US5840338A
(en)
*
|
1994-07-18 |
1998-11-24 |
Roos; Eric J. |
Loading of biologically active solutes into polymer gels
|
US5603955A
(en)
*
|
1994-07-18 |
1997-02-18 |
University Of Cincinnati |
Enhanced loading of solutes into polymer gels
|
GB9415290D0
(en)
|
1994-07-28 |
1994-09-21 |
Zeneca Ltd |
Gel formation
|
US5599534A
(en)
*
|
1994-08-09 |
1997-02-04 |
University Of Nebraska |
Reversible gel-forming composition for sustained delivery of bio-affecting substances, and method of use
|
US5827835A
(en)
*
|
1994-08-30 |
1998-10-27 |
Alcon Laboratories, Inc. |
Thermally-gelling emulsions
|
AU686455B2
(en)
*
|
1994-08-30 |
1998-02-05 |
Alcon Laboratories, Inc. |
Thermally-gelling drug delivery vehicles containing cellulose ethers
|
US5516808A
(en)
*
|
1994-10-27 |
1996-05-14 |
Sawaya; Assad S. |
Topical cellulose pharmaceutical formulation
|
US5985383A
(en)
*
|
1995-03-15 |
1999-11-16 |
Acushnet Company |
Conforming shoe construction and gel compositions therefor
|
US5955159A
(en)
*
|
1995-03-15 |
1999-09-21 |
Acushnet Company |
Conforming shoe construction using gels and method of making the same
|
US5939157A
(en)
*
|
1995-10-30 |
1999-08-17 |
Acushnet Company |
Conforming shoe construction using gels and method of making the same
|
US5939485A
(en)
*
|
1995-06-19 |
1999-08-17 |
Medlogic Global Corporation |
Responsive polymer networks and methods of their use
|
DE19511322C2
(de)
*
|
1995-03-28 |
1999-09-02 |
Mann Gerhard Chem Pharm Fab |
Sterile Augengele mit einem Gehalt an mittelkettigen Triglyceriden und Verfahren zu deren Herstellung
|
WO1997000275A2
(en)
*
|
1995-06-16 |
1997-01-03 |
Gel Sciences, Inc. |
Responsive polymer networks and methods of their use
|
JP3766707B2
(ja)
*
|
1995-10-25 |
2006-04-19 |
ディップソール株式会社 |
亜鉛及び亜鉛合金の撥水処理用水溶性組成物及び撥水処理方法
|
US5766704A
(en)
*
|
1995-10-27 |
1998-06-16 |
Acushnet Company |
Conforming shoe construction and gel compositions therefor
|
US6610292B2
(en)
|
1995-11-22 |
2003-08-26 |
Ista Pharmaceuticals, Inc. |
Use of hyaluronidase in the manufacture of an ophthalmic preparation for liquefying vitreous humor in the treatment of eye disorders
|
US5866120A
(en)
*
|
1995-11-22 |
1999-02-02 |
Advanced Corneal Systems, Inc. |
Method for accelerating clearance of hemorrhagic blood from the vitreous humor with hyaluronidase
|
WO1997020578A1
(en)
*
|
1995-12-04 |
1997-06-12 |
University Of Miami |
Non-preserved topical corticosteroid for treatment of dry eye, filamentary keratitis, and delayed tear clearance
|
US5723131A
(en)
*
|
1995-12-28 |
1998-03-03 |
Johnson & Johnson Vision Products, Inc. |
Contact lens containing a leachable absorbed material
|
US6280745B1
(en)
|
1997-12-23 |
2001-08-28 |
Alliance Pharmaceutical Corp. |
Methods and compositions for the delivery of pharmaceutical agents and/or the prevention of adhesions
|
US5945100A
(en)
|
1996-07-31 |
1999-08-31 |
Fbp Corporation |
Tumor delivery vehicles
|
WO1998006438A2
(en)
*
|
1996-08-12 |
1998-02-19 |
Medlogic Global Corporation |
Composition for pharmaceutical applications
|
US5888493A
(en)
*
|
1996-12-05 |
1999-03-30 |
Sawaya; Assad S. |
Ophthalmic aqueous gel formulation and related methods
|
WO1998029487A1
(en)
*
|
1997-01-02 |
1998-07-09 |
Medlogic Global Corporation |
Responsive polymer networks and methods of their use
|
AU6134298A
(en)
*
|
1997-01-24 |
1998-08-18 |
Medlogic Global Corporation |
Conformable structures
|
CA2291622C
(en)
*
|
1997-06-06 |
2007-09-04 |
Anna Gutowska |
Reversible geling co-polymer and method of making
|
GB9718568D0
(en)
|
1997-09-03 |
1997-11-05 |
Chauvin Pharmaceuticals Limite |
Compositions
|
US20040063678A1
(en)
*
|
1997-10-06 |
2004-04-01 |
Bausch & Lomb Incorporated |
Dexamethasone Gel
|
DE19744113A1
(de)
*
|
1997-10-06 |
1999-04-15 |
Mann Gerhard Chem Pharm Fab |
Dexamethason-Gel
|
US6417247B1
(en)
*
|
1997-10-14 |
2002-07-09 |
Beth L. Armstrong |
Polymer/ceramic composites
|
CA2316248A1
(en)
*
|
1997-12-23 |
1999-07-01 |
Alliance Pharmaceutical Corp. |
Methods and compositions for the delivery of pharmaceutical agents and/or the prevention of adhesions
|
US20040228794A1
(en)
*
|
1998-04-10 |
2004-11-18 |
Battelle Memorial Institute |
Therapeutic agent carrier compositions
|
US6159483A
(en)
*
|
1998-06-01 |
2000-12-12 |
Colgate-Palmolive Company |
Stabilized liquid aqueous composition
|
US5968480A
(en)
*
|
1998-07-09 |
1999-10-19 |
Colgate Palmolive Company |
Oral composition exhibiting enhanced antiplaque efficacy
|
US6337130B1
(en)
|
1998-07-30 |
2002-01-08 |
Zeneca Limited |
Acid-triggered release microcapsules
|
US6316011B1
(en)
|
1998-08-04 |
2001-11-13 |
Madash, Llc |
End modified thermal responsive hydrogels
|
CA2345414A1
(en)
*
|
1998-09-28 |
2000-04-06 |
Santen Pharmaceutical Co., Ltd. |
Eyedrops for promoting lacrimal secretion or treating keratoconjunctival disorders containing natriuretic peptide as active ingredient
|
US6312666B1
(en)
|
1998-11-12 |
2001-11-06 |
3M Innovative Properties Company |
Methods of whitening teeth
|
US6669927B2
(en)
|
1998-11-12 |
2003-12-30 |
3M Innovative Properties Company |
Dental compositions
|
US6312667B1
(en)
|
1998-11-12 |
2001-11-06 |
3M Innovative Properties Company |
Methods of etching hard tissue in the oral environment
|
US6451346B1
(en)
*
|
1998-12-23 |
2002-09-17 |
Amgen Inc |
Biodegradable pH/thermosensitive hydrogels for sustained delivery of biologically active agents
|
US6245740B1
(en)
*
|
1998-12-23 |
2001-06-12 |
Amgen Inc. |
Polyol:oil suspensions for the sustained release of proteins
|
IL146801A0
(en)
*
|
1999-06-11 |
2002-07-25 |
Pro Duct Health Inc |
Gel composition for filling a breast milk duct prior to surgical excision of the duct or other breast tissue
|
US6521431B1
(en)
|
1999-06-22 |
2003-02-18 |
Access Pharmaceuticals, Inc. |
Biodegradable cross-linkers having a polyacid connected to reactive groups for cross-linking polymer filaments
|
US20040037891A1
(en)
*
|
1999-10-04 |
2004-02-26 |
Karagoezian Hampar L. |
Synergistic antimicrobial ophthalmic and dermatologic preparations containing chlorite and hydrogen peroxide
|
US20040234457A1
(en)
*
|
1999-10-19 |
2004-11-25 |
The Procter & Gamble Company |
Methods of preventing and treating SARS using low pH respiratory tract compositions
|
US20040033260A1
(en)
*
|
1999-10-19 |
2004-02-19 |
The Procter & Gamble Company |
Compositions for prevention and treatment of cold and influenza-like symptoms comprising chelated zinc
|
WO2001041735A2
(en)
*
|
1999-12-07 |
2001-06-14 |
Amgen Inc. |
Thermosensitive biodegradable hydrogels based on low molecular weight pluronics
|
FR2802097B1
(fr)
*
|
1999-12-14 |
2002-12-13 |
Invest S Therapeutiques Essais |
Composition sous forme de gel prevue pour recevoir un principe actif en solution ou en suspension, notamment pour application sur une muqueuse et procede de fabrication
|
TWI227143B
(en)
|
1999-12-15 |
2005-02-01 |
Guo-Jiun Sung |
In situ gel formation for ophthalmic delivery by combining Pluronic/Carbopol medic composition and its preparing method
|
US6660247B1
(en)
*
|
2000-06-23 |
2003-12-09 |
Battelle Memorial Institute |
Multiple stimulus reversible hydrogels
|
US6303290B1
(en)
|
2000-09-13 |
2001-10-16 |
The Trustees Of The University Of Pennsylvania |
Encapsulation of biomaterials in porous glass-like matrices prepared via an aqueous colloidal sol-gel process
|
US7803392B2
(en)
*
|
2000-12-27 |
2010-09-28 |
University Of Kentucky Research Foundation |
pH-Sensitive mucoadhesive film-forming gels and wax-film composites suitable for topical and mucosal delivery of molecules
|
WO2002064114A1
(en)
*
|
2001-02-15 |
2002-08-22 |
Sanwa Kagaku Kenkyusho Co., Ltd. |
Novel ophthalmic compositions
|
EP1372573B1
(en)
*
|
2001-03-21 |
2009-10-07 |
Madash LLC |
Thermally reversible water in oil in water emulsions
|
JP2003089752A
(ja)
*
|
2001-03-23 |
2003-03-28 |
Canon Inc |
刺激応答性ポリマーを含む組成物、それを含むインク組成物、並びに該インク組成物を用いた画像形成方法および装置
|
FR2823439A1
(fr)
*
|
2001-04-13 |
2002-10-18 |
Oreal |
Composition de bain gelifiantes, relaxantes
|
DE10132876A1
(de)
*
|
2001-07-06 |
2003-01-30 |
Medproject Pharma Entwicklungs |
Zweiphasige, tropfbare Hydrogele zur Anwendung am Auge
|
US20030082235A1
(en)
*
|
2001-08-13 |
2003-05-01 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Novel reverse thermo-sensitive block copolymers
|
US20080063620A1
(en)
*
|
2001-08-13 |
2008-03-13 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Novel reverse thermo-sensitive block copolymers
|
US6620405B2
(en)
|
2001-11-01 |
2003-09-16 |
3M Innovative Properties Company |
Delivery of hydrogel compositions as a fine mist
|
US20070196415A1
(en)
*
|
2002-11-14 |
2007-08-23 |
Guohua Chen |
Depot compositions with multiple drug release rate controls and uses thereof
|
ATE507816T1
(de)
*
|
2001-11-14 |
2011-05-15 |
Durect Corp |
Injizierbare depotzusammensetzungen und deren verwendung
|
CA2467239A1
(en)
|
2001-11-14 |
2003-05-22 |
Alza Corporation |
Catheter injectable depot compositions and uses thereof
|
US7204997B2
(en)
*
|
2002-01-29 |
2007-04-17 |
Supratek Pharma Inc. |
Responsive microgel and methods related thereto
|
WO2003080119A1
(en)
*
|
2002-03-26 |
2003-10-02 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Responsive biomedical composites
|
US20030204180A1
(en)
*
|
2002-04-30 |
2003-10-30 |
Kimberly-Clark Worldwide, Inc. |
Temperature responsive delivery systems
|
EP1878447A3
(en)
*
|
2002-05-09 |
2008-12-31 |
Ultrast LLC |
Medium for contrast enhancement or convenience for ultrasonic, endoscopic and other medical examinations
|
PL374188A1
(en)
*
|
2002-05-09 |
2005-10-03 |
Ultrast Llc |
Medium for contrast enhancement use for ultrasonic, endoscopic and other medical examinations
|
DE10224352A1
(de)
*
|
2002-06-01 |
2003-12-11 |
Mueller Schulte Detlef |
Thermosensitive Polymerträger mit veränderbarer physikalischer Struktur für die biochemische Analytik, Diagnostik und Therapie
|
JP3891571B2
(ja)
*
|
2002-06-14 |
2007-03-14 |
キヤノン株式会社 |
機能性組成物、それを用いた画像形成方法及び画像形成装置
|
US20040001889A1
(en)
|
2002-06-25 |
2004-01-01 |
Guohua Chen |
Short duration depot formulations
|
ES2319400T3
(es)
|
2002-07-31 |
2009-05-07 |
Durect Corporation |
Composiciones deposito inyectables y empleo de las mismas.
|
MXPA05001244A
(es)
|
2002-07-31 |
2005-06-08 |
Alza Corp |
Composiciones de deposito de polimero multimodal inyectable y usos de las mismas.
|
CN101336887A
(zh)
*
|
2002-12-04 |
2009-01-07 |
参天制药株式会社 |
结膜下给药用药物组合物
|
US20040185013A1
(en)
*
|
2003-01-30 |
2004-09-23 |
Burgio Paul A. |
Dental whitening compositions and methods
|
US20040151691A1
(en)
*
|
2003-01-30 |
2004-08-05 |
Oxman Joel D. |
Hardenable thermally responsive compositions
|
US7223826B2
(en)
*
|
2003-01-30 |
2007-05-29 |
3M Innovative Properties Company |
Amide-functional polymers, compositions, and methods
|
IL155866A0
(en)
*
|
2003-05-12 |
2003-12-23 |
Yissum Res Dev Co |
Responsive polymeric system
|
CA2839847C
(en)
|
2003-06-13 |
2016-03-15 |
Masood A. Chowhan |
Ophthalmic compositions containing a synergistic combination of two polymers
|
US7914803B2
(en)
|
2003-06-13 |
2011-03-29 |
Alcon, Inc. |
Ophthalmic compositions containing a synergistic combination of three polymers
|
TWI336257B
(en)
|
2003-06-13 |
2011-01-21 |
Alcon Inc |
Ophthalmic compositions containing a synergistic combination of three polymers
|
US7947295B2
(en)
|
2003-06-13 |
2011-05-24 |
Alcon, Inc. |
Ophthalmic compositions containing a synergistic combination of two polymers
|
US20050002996A1
(en)
*
|
2003-07-02 |
2005-01-06 |
Milan Sojka |
Sustained release compositions and controlled delivery method
|
US20050059583A1
(en)
|
2003-09-15 |
2005-03-17 |
Allergan, Inc. |
Methods of providing therapeutic effects using cyclosporin components
|
DE10350248A1
(de)
*
|
2003-10-28 |
2005-06-16 |
Magnamedics Gmbh |
Thermosensitive, biokompatible Polymerträger mit veränderbarer physikalischer Struktur für die Therapie, Diagnostik und Analytik
|
GB2408937A
(en)
*
|
2003-12-09 |
2005-06-15 |
Johnson & Johnson Medical Ltd |
pH dependent medicinal compositions
|
GB0329507D0
(en)
*
|
2003-12-19 |
2004-01-28 |
Guillon Michel |
Contect lens
|
EP2457580A1
(en)
|
2004-08-25 |
2012-05-30 |
The UAB Research Foundation |
Absorption enhancers for drug administration
|
US8268791B2
(en)
|
2004-08-25 |
2012-09-18 |
Aegis Therapeutics, Llc. |
Alkylglycoside compositions for drug administration
|
US20090047347A1
(en)
*
|
2005-07-29 |
2009-02-19 |
Aegis Therapeutics, Inc. |
Compositions for Drug Administration
|
US20140162965A1
(en)
|
2004-08-25 |
2014-06-12 |
Aegis Therapeutics, Inc. |
Compositions for oral drug administration
|
US20060046962A1
(en)
|
2004-08-25 |
2006-03-02 |
Aegis Therapeutics Llc |
Absorption enhancers for drug administration
|
US9114069B2
(en)
|
2004-08-25 |
2015-08-25 |
Aegis Therapeutics, Llc |
Antibacterial compositions for drug administration
|
US9895444B2
(en)
|
2004-08-25 |
2018-02-20 |
Aegis Therapeutics, Llc |
Compositions for drug administration
|
US20060089590A1
(en)
*
|
2004-10-27 |
2006-04-27 |
John Higuchi |
Methods and devices for sustained in-vivo release of an active agent
|
US20060142234A1
(en)
*
|
2004-12-23 |
2006-06-29 |
Guohua Chen |
Injectable non-aqueous suspension
|
US20060147485A1
(en)
*
|
2005-01-04 |
2006-07-06 |
Morten Pedersen |
Oil-in-water formulation of avermectins
|
DE102005035879A1
(de)
*
|
2005-07-30 |
2007-02-01 |
Paul Hartmann Ag |
Hydrogel
|
US20070048338A1
(en)
*
|
2005-08-26 |
2007-03-01 |
Ladd Byron S |
Compositions and methods for surface treatment in medical and surgical procedures
|
US7982066B2
(en)
|
2005-12-09 |
2011-07-19 |
Novalife, Inc. |
High protein supplement
|
US20070248629A1
(en)
*
|
2006-04-20 |
2007-10-25 |
Friden Phillip M |
Pharmaceutical formulations for iontophoretic drug delivery
|
EP2012706A4
(en)
*
|
2006-04-20 |
2013-02-13 |
Transport Pharmaceuticals Inc |
PHARMACEUTICAL FORMULATIONS FOR IONTOPHORETIC METHOTREXATE RELEASE
|
EP2035015A4
(en)
*
|
2006-05-01 |
2009-11-11 |
Riolan Technologies Inc |
COMPOSITIONS, METHODS AND KITS FOR DRY EYE TREATMENT
|
EP1873205A1
(en)
*
|
2006-06-12 |
2008-01-02 |
Corning Incorporated |
Thermo-responsive blends and uses thereof
|
EP2158898A1
(en)
|
2006-06-23 |
2010-03-03 |
Aegis Therapeutics LLC |
Stabilizing alkylglycoside compositions and method thereof
|
US8226949B2
(en)
|
2006-06-23 |
2012-07-24 |
Aegis Therapeutics Llc |
Stabilizing alkylglycoside compositions and methods thereof
|
ES2525476T3
(es)
|
2006-08-31 |
2014-12-23 |
Clinuvel Pharmaceuticals Limited |
Derivados de alfa-MSH para el tratamiento de fotodermatosis
|
JPWO2008053810A1
(ja)
*
|
2006-10-30 |
2010-02-25 |
三井化学株式会社 |
pH応答性ゲルおよびその製造方法、ならびにpH応答性バルブ
|
RU2340327C1
(ru)
*
|
2007-05-03 |
2008-12-10 |
Лев Давидович Раснецов |
Офтальмологический гель и способ его приготовления
|
WO2008137872A1
(en)
*
|
2007-05-04 |
2008-11-13 |
Personics Holdings Inc. |
Earguard sealing system i: multi-chamber systems
|
EP2197461B1
(en)
|
2007-10-08 |
2018-02-21 |
Aurinia Pharmaceuticals Inc. |
Ophthalmic compositions comprising calcineurin inhibitors or mtor inhibitors
|
US8718313B2
(en)
*
|
2007-11-09 |
2014-05-06 |
Personics Holdings, LLC. |
Electroactive polymer systems
|
DE102007059939A1
(de)
|
2007-12-12 |
2009-06-18 |
Müller-Schulte, Detlef, Dr. |
Auflösbare, magnetische und unmagnetische Polymerträger zur Abtrennung und Wiedergewinnung von Zellen und Biosubstanzen
|
US8142870B2
(en)
*
|
2007-12-13 |
2012-03-27 |
Personics Holdings Inc. |
Energy responsive conformal device
|
US9107815B2
(en)
|
2008-02-22 |
2015-08-18 |
Allergan, Inc. |
Sustained release poloxamer containing pharmaceutical compositions
|
SI2957292T1
(en)
|
2008-03-27 |
2018-04-30 |
Clinuvel Pharmaceuticals Limited |
Vitiligo therapy
|
US20090258865A1
(en)
|
2008-03-28 |
2009-10-15 |
Hale Biopharma Ventures, Llc |
Administration of benzodiazepine compositions
|
KR101101321B1
(ko)
*
|
2008-11-03 |
2012-01-02 |
주식회사 엠씨티티 |
상처 치유를 위한 하이드로 겔 형태의 세포전달용 비히클 및 그 제조방법
|
US8440631B2
(en)
|
2008-12-22 |
2013-05-14 |
Aegis Therapeutics, Llc |
Compositions for drug administration
|
US9017725B2
(en)
|
2009-06-09 |
2015-04-28 |
Aurinia Pharmaceuticals Inc. |
Topical drug delivery systems for ophthalmic use
|
IT1397132B1
(it)
*
|
2009-12-01 |
2013-01-04 |
Alfa Wassermann Spa |
Composizioni comprendenti antiinfiammatori non steroidei.
|
CN102892713B
(zh)
|
2010-02-10 |
2016-05-04 |
金斯顿女王大学 |
具有可转换的离子强度的水
|
US11419329B2
(en)
|
2010-03-12 |
2022-08-23 |
Monsanto Technology Llc |
Agrochemical gel compositions
|
US10154923B2
(en)
|
2010-07-15 |
2018-12-18 |
Eyenovia, Inc. |
Drop generating device
|
WO2012009696A2
(en)
|
2010-07-15 |
2012-01-19 |
Corinthian Ophthalmic, Inc. |
Ophthalmic drug delivery
|
CA2805426C
(en)
|
2010-07-15 |
2020-03-24 |
Corinthian Ophthalmic, Inc. |
Drop generating device
|
WO2012009702A1
(en)
|
2010-07-15 |
2012-01-19 |
Corinthian Ophthalmic, Inc. |
Method and system for performing remote treatment and monitoring
|
BR112013014972B1
(pt)
|
2010-12-15 |
2020-12-29 |
Queen's University At Kingston |
método para remover um soluto da solução aquosa ou para concentrar a solução aquosa diluida através da modulação da força iônica de uma solução aquosa
|
GB201100820D0
(en)
|
2011-01-18 |
2011-03-02 |
Guillon Michel |
Lenses
|
EP2487185A1
(en)
|
2011-02-11 |
2012-08-15 |
Clinuvel Pharmaceuticals Limited |
Hexapeptide with improved activity in the repair of cellular DNA of dermal cells
|
CA2827559A1
(en)
|
2011-02-22 |
2012-08-30 |
Regents Of The University Of Minnesota |
Silica encapsulated biomaterials
|
US20160144038A1
(en)
|
2014-11-20 |
2016-05-26 |
Broda International, LLC |
Water-soluble supramolecular complexes
|
HUE042252T2
(hu)
|
2011-03-21 |
2019-06-28 |
Broda Tech Co Ltd |
Fordítottan hõ-reverzibilis hidrogél kompozíciók
|
WO2012145470A2
(en)
*
|
2011-04-22 |
2012-10-26 |
Alcon Research, Ltd. |
Ophthalmic composition with a viscosity enhancement system having two different viscosity enhancing agents
|
WO2012158962A2
(en)
|
2011-05-18 |
2012-11-22 |
Eumederis Pharmaceuticals, Inc. |
Improved peptide pharmaceuticals
|
PL3415139T3
(pl)
|
2011-06-14 |
2022-07-11 |
Neurelis, Inc. |
Podawanie benzodiazepiny
|
AU2012312816A1
(en)
|
2011-09-22 |
2014-04-24 |
Bausch & Lomb Incorporated |
Ophthalmic gel compositions
|
WO2014035451A1
(en)
|
2012-08-31 |
2014-03-06 |
Bausch & Lomb Incorporated |
Ophthalmic compositions with wax esters
|
US20130101547A1
(en)
|
2011-10-19 |
2013-04-25 |
Allergan, Inc. |
Thermoresponsive compositions for dermatological use and methods thereof
|
WO2013090468A1
(en)
|
2011-12-12 |
2013-06-20 |
Corinthian Ophthalmic, Inc. |
High modulus polymeric ejector mechanism, ejector device, and methods of use
|
JP6282231B2
(ja)
*
|
2012-01-23 |
2018-02-21 |
アラーガン、インコーポレイテッドAllergan,Incorporated |
固化するデポー形成の注入可能な薬物製剤に懸濁される持続放出された生分解性または生体侵食性微小球または微小粒子
|
EP3434696A1
(en)
|
2012-11-20 |
2019-01-30 |
Mederis Diabetes, LLC |
Improved peptide pharmaceuticals for insulin resistance
|
DK3444281T3
(da)
|
2012-11-20 |
2022-02-07 |
Eumederis Pharmaceuticals Inc |
Forbedrede peptidlægemidler
|
US9534236B2
(en)
|
2013-03-08 |
2017-01-03 |
Regents Of The University Of Minnesota |
Membranes for wastewater-generated energy and gas
|
JP6564369B2
(ja)
|
2013-12-09 |
2019-08-21 |
デュレクト コーポレイション |
薬学的活性剤複合体、ポリマー複合体、ならびにこれらを伴う組成物及び方法
|
CN117180445A
(zh)
|
2014-05-28 |
2023-12-08 |
梅德瑞斯糖尿病有限责任公司 |
针对胰岛素抵抗的改良肽药物
|
US10035719B2
(en)
|
2014-10-15 |
2018-07-31 |
Regents Of The University Of Minnesota |
System and membrane for wastewater-generated energy and gas
|
HUE059639T2
(hu)
|
2015-01-26 |
2022-12-28 |
Bausch & Lomb |
Szemészeti szuszpenzió kompozíció
|
US10010502B2
(en)
|
2015-05-19 |
2018-07-03 |
Amorphex Therapeutics Llc |
Device that delivers a sustained low-dose of a myopia-suppressing drug, while preserving pupillary function and accommodation
|
AU2016344349B2
(en)
|
2015-10-25 |
2022-05-19 |
Iview Therapeutics, Inc. |
Pharmaceutical formulations that form gel in situ
|
US20190224275A1
(en)
|
2017-05-12 |
2019-07-25 |
Aurinia Pharmaceuticals Inc. |
Protocol for treatment of lupus nephritis
|
CN111093742B
(zh)
|
2017-06-10 |
2022-09-16 |
艾诺维亚股份有限公司 |
用于处理流体并将流体输送到眼睛的方法和设备
|
IL311775A
(en)
|
2018-01-03 |
2024-05-01 |
Mederis Diabetes Llc |
Improved peptide drugs for the treatment of NASH and other disorders
|
JP6941224B2
(ja)
|
2018-02-06 |
2021-09-29 |
イージス セラピューティクス,エルエルシー |
疾患の処置のための鼻腔内エピネフリン製剤及び方法
|
JP2022507982A
(ja)
*
|
2018-11-26 |
2022-01-18 |
アイビバ バイオファーマ インコーポレイテッド |
薬剤送達用生体溶解性医薬ゲル
|
BR112022013784A2
(pt)
|
2020-01-13 |
2022-10-11 |
Durect Corp |
Sistemas de distribuição de fármacos de liberação prolongada com impurezas reduzidas e métodos relacionados
|